Pinkie Jacob Eravuchira

Dr. Pinkie Jacob Eravuchira

Environment and People, A Center for Scientific Research and Innovation, Kerala, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2020 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
Pinkie Jacob EravuchiraPinkie Jacob Eravuchira
Pinkie Jacob Eravuchira
MBMartina Banchelli
Martina Banchelli
CDCristiano D'Andrea
Cristiano D'Andrea
MAMarella de Angelis
Marella de Angelis
PMPaolo Matteini
Paolo Matteini
Israel GannotIsrael Gannot
Israel Gannot
Alzheimer’s disease (AD) is a chronic, progressive, neurodegenerative disorder that affects several million people worldwide.1 – 4 AD is considered as one of the leading causes of dementia, and it is ranked as the fifth major cause of death. AD is pathologically characterized by the deposition of extracellular plaques composed of amyloid β-peptide (Aβ) and the aggregation of tau protein as intracellular neurofibrillary tangles in the brain.5 – 10 Specifically, the entorhinalcortex and hippocampus, which are brain areas dealing with cognitive abilities, are critically affected by the deposition of plaques and tangles in such a way that cognitive disabilities, including memory impairment, difficulties with reasoning and solving problems, and challenges with time and space, are among the prime distinctive symptoms of AD. The current antemortem AD diagnosis is based on monitoring the mental decline and on neuropsychological and laboratory tests. Nevertheless, the conclusive diagnosis of AD is still challenging requiring an autopsy substantiation of disease pathology.